← All trials
NCT00821860
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2003
- Primary completion
- Feb 28, 2013
- Completion date
- May 31, 2013
- First posted
- Jan 14, 2009
- Last posted
- Jun 28, 2013
- Enrollment
- 196
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Papworth Hospital NHS Foundation TrustLead sponsor
- Papworth Hospital NHS Foundation TrustOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.